{"id":8542,"date":"2012-04-23T11:40:32","date_gmt":"2012-04-23T02:40:32","guid":{"rendered":"https:\/\/www.hoya.com\/?post_type=news&#038;p=8542"},"modified":"2022-11-29T22:06:33","modified_gmt":"2022-11-29T13:06:33","slug":"20120423","status":"publish","type":"news","link":"https:\/\/www.hoya.com\/en\/news\/20120423\/","title":{"rendered":"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market"},"content":{"rendered":"<p><strong>Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market<\/strong><\/p>\n<p>CHINO HILLS, CA. &#8211; HOYA Surgical Optics, Inc. (HSO) announced today that they have received approval from the FDA to commercially distribute two models of clear foldable hydrophobic acrylic-optic aspheric intraocular lenses; the iSymm(TM) Intraocular Lens (Model FC-60AD) and the preloaded iSert(TM) Intraocular Lens (Model PC-60AD) in the U.S.<\/p>\n<p>HOYA Surgical Optics is focused on helping ophthalmic surgeons confidently build their premium practices and believes that every patient is a premium patient. These lenses are an important addition to HSO\u2019s line of foldable and pre-loaded IOL\u2019s available with the Optimized Aspheric(TM) design.<br \/>\nJake Vander Zanden, President, Americas stated \u201cHOYA Surgical Optics remains strongly committed to our U.S. customers and delivering on this new direction in refractive cataract surgery. Our COMPLETE SYSTEM(TM) uses the HOYA iTrace(R) Surgical Workstation with advanced wavefront diagnostics to assist surgeons in the proper selection of an IOL, based on the patient\u2019s specific optical system.\u201d<\/p>\n<p>This approval is another first in the US ophthalmology marketplace. HOYA Surgical Optics is the only company offering both UV Absorbing (clear) and Blue Light Filtering (yellow) IOL\u2019s in preloaded and cartridge style configurations. Any customers in need of assistance are asked to contact their Sales Representative or call Hoya Surgical Optics Customer Service toll-free at 866-750-5870.<\/p>\n<p>About HOYA Surgical Optics<br \/>\nHOYA Surgical Optics is a leading global ophthalmic device company with an entrepreneurial spirit focused on what matters most to realize both exceptional patient outcomes and better practice results. Leveraging more than 70 years of excellence in optics design and innovation that has been the hallmark of the HOYA Corporation, HOYA Surgical Optics provides ophthalmologists with innovative ophthalmic devices and services in key strategic segments that help them elevate their quality of care and business efficiencies.<\/p>\n","protected":false},"author":10,"featured_media":0,"template":"","class_list":["post-8542","news","type-news","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market - HOYA Corporation<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hoya.com\/en\/news\/20120423\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market - HOYA Corporation\" \/>\n<meta property=\"og:description\" content=\"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market CHINO HILLS, CA. &#8211; HOYA Surgical Optics, Inc. (HSO) announced today that they have received approval from the FDA to commercially distribute two models of clear foldable hydrophobic acrylic-optic aspheric intraocular lenses; the iSymm(TM) Intraocular Lens (Model FC-60AD) and the preloaded iSert(TM) Intraocular Lens (Model PC-60AD) in the U.S. HOYA Surgical Optics is focused on helping ophthalmic surgeons confidently build their premium practices and believes that every patient is a premium patient. These lenses are an important addition to HSO\u2019s line of foldable and pre-loaded IOL\u2019s available with the Optimized Aspheric(TM) design. Jake Vander Zanden, President, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hoya.com\/en\/news\/20120423\/\" \/>\n<meta property=\"og:site_name\" content=\"HOYA Corporation\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-29T13:06:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.hoya.com\/en\/news\/20120423\/\",\"url\":\"https:\/\/www.hoya.com\/en\/news\/20120423\/\",\"name\":\"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market - HOYA Corporation\",\"isPartOf\":{\"@id\":\"https:\/\/www.hoya.com\/en\/#website\"},\"datePublished\":\"2012-04-23T02:40:32+00:00\",\"dateModified\":\"2022-11-29T13:06:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.hoya.com\/en\/news\/20120423\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.hoya.com\/en\/news\/20120423\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.hoya.com\/en\/news\/20120423\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.hoya.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News Releases\",\"item\":\"https:\/\/www.hoya.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.hoya.com\/en\/#website\",\"url\":\"https:\/\/www.hoya.com\/en\/\",\"name\":\"HOYA Corporation\",\"description\":\" \",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.hoya.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market - HOYA Corporation","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hoya.com\/en\/news\/20120423\/","og_locale":"en_US","og_type":"article","og_title":"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market - HOYA Corporation","og_description":"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market CHINO HILLS, CA. &#8211; HOYA Surgical Optics, Inc. (HSO) announced today that they have received approval from the FDA to commercially distribute two models of clear foldable hydrophobic acrylic-optic aspheric intraocular lenses; the iSymm(TM) Intraocular Lens (Model FC-60AD) and the preloaded iSert(TM) Intraocular Lens (Model PC-60AD) in the U.S. HOYA Surgical Optics is focused on helping ophthalmic surgeons confidently build their premium practices and believes that every patient is a premium patient. These lenses are an important addition to HSO\u2019s line of foldable and pre-loaded IOL\u2019s available with the Optimized Aspheric(TM) design. Jake Vander Zanden, President, [&hellip;]","og_url":"https:\/\/www.hoya.com\/en\/news\/20120423\/","og_site_name":"HOYA Corporation","article_modified_time":"2022-11-29T13:06:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.hoya.com\/en\/news\/20120423\/","url":"https:\/\/www.hoya.com\/en\/news\/20120423\/","name":"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market - HOYA Corporation","isPartOf":{"@id":"https:\/\/www.hoya.com\/en\/#website"},"datePublished":"2012-04-23T02:40:32+00:00","dateModified":"2022-11-29T13:06:33+00:00","breadcrumb":{"@id":"https:\/\/www.hoya.com\/en\/news\/20120423\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hoya.com\/en\/news\/20120423\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hoya.com\/en\/news\/20120423\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hoya.com\/en\/"},{"@type":"ListItem","position":2,"name":"News Releases","item":"https:\/\/www.hoya.com\/en\/news\/"},{"@type":"ListItem","position":3,"name":"Hoya Surgical Optics Announces FDA Approval of Clear Optic IOL\u2019s for the US Market"}]},{"@type":"WebSite","@id":"https:\/\/www.hoya.com\/en\/#website","url":"https:\/\/www.hoya.com\/en\/","name":"HOYA Corporation","description":" ","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hoya.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.hoya.com\/en\/wp-json\/wp\/v2\/news\/8542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hoya.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.hoya.com\/en\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.hoya.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/www.hoya.com\/en\/wp-json\/wp\/v2\/news\/8542\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hoya.com\/en\/wp-json\/wp\/v2\/media?parent=8542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}